Standard Biotools
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $21,762 | $40,795 | $46,718 | $44,969 |
Gross Profit | 1,936 | 19,741 | 21,905 | 23,261 |
EBITDA | -16,268 | -22,011 | -29,847 | -23,228 |
EBIT | -18,273 | -26,182 | -33,800 | -26,659 |
Net Income | -33,459 | -26,033 | -34,072 | -26,938 |
Net Change In Cash | 21,762 | 40,795 | 46,718 | 44,969 |
Free Cash Flow | -22,555 | -35,337 | -17,441 | -30,124 |
Cash | 158,617 | 150,880 | 166,728 | 210,647 |
Basic Shares | 379,369 | 378,228 | 374,544 | 371,538 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $174,432 | $106,340 | $97,948 | $130,581 |
Gross Profit | 84,262 | 50,450 | 37,051 | 77,266 |
EBITDA | -118,135 | -54,457 | -173,570 | -44,257 |
EBIT | -134,996 | -69,637 | -188,597 | -67,459 |
Net Income | -138,885 | -74,656 | -190,098 | -59,237 |
Net Change In Cash | 174,432 | 106,340 | 97,948 | 130,581 |
Cost of Revenue | 53,261 | |||
Free Cash Flow | -151,809 | -46,118 | -93,195 | -57,325 |
Cash | 166,728 | 51,704 | 81,309 | 28,451 |
Basic Shares | 353,245 | 79,160 | 78,305 | 75,786 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.02 |
2025-03-31 | -$0.04 |
2024-12-31 | -$0.04 |
